FLEM BALLET: Open Payments
NPI 1295401198 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 36 payments from 10 companies in 2025. Trend: 2023 $1,152 · 2024 $589 · 2025 $825
Food & beverage: $748Education: $77
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $148 |
| Vanda Pharmaceuticals Inc. | 2 | $147 |
| Otsuka America Pharmaceutical, Inc. | 4 | $130 |
| E.R. Squibb & Sons, L.L.C. | 6 | $103 |
| Alkermes, Inc. | 5 | $102 |
| Lundbeck LLC | 2 | $77 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| ABBVIE INC. | 2 | $35 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: FANAPT, AUSTEDO XR, COBENFY, REXULTI, ABILIFY MAINTENA, ARISTADA, VRAYLAR, UZEDY.
Industry payments across LA — which companies pay providers there.
